Balyasny Asset Management L.P.
Position in ACAD — Acadia Pharmaceuticals Inc
CIK 1218710
Chicago, IL
Position in ACAD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,966,979
+$6,966,979 QoQ
Shares Held
312,982
Ownership
0.183%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
13 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Derivatives in ACAD
reported options exposure · as of Mar 31, 2025CallValue
$1,661,000
CallShares
100,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Balyasny Asset Management L.P. holds $2,162,785,356 across 177 Biotechnology names. ACAD ranks #79 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
2,779,445 | $146,532,340 | |
| 2 | ERAS |
Erasca, Inc.
|
5,143,985 | $83,229,677 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
3,826,659 | $80,053,706 | |
| 4 | APLS |
Apellis Pharmaceuticals, Inc.
|
1,917,501 | $77,141,065 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,362,752 | $76,981,860 | |
| 6 | CYTK |
Cytokinetics Inc
|
992,545 | $65,418,640 | |
| 7 | DAWN |
Day One Biopharmaceuticals, Inc.
|
2,625,235 | $56,285,038 | |
| 8 | FOLD |
AMICUS THERAPEUTICS, INC.
|
3,827,513 | $55,345,837 |
All Filings in ACAD
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,966,979 | 312,982 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $1,661,000 | 100,000 | Call | Sole | 2025-05-15 | |
| 2024-12-31 | $7,283,518 | 396,922 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $17,295,917 | 1,124,572 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $12,547,372 | 772,146 | Shares | Sole | 2024-08-14 | |
| 2024-06-30 | $3,250,000 | 200,000 | Call | Sole | 2024-08-14 | |
| 2023-12-31 | $9,420,395 | 300,875 | Shares | Other | 2024-02-14 | |
| 2023-12-31 | $3,131,000 | 100,000 | Call | Sole | 2024-02-14 | |
| 2023-09-30 | $340,067 | 16,318 | Shares | Other | 2023-11-14 | |
| 2022-12-31 | $41,041 | 2,578 | Shares | Other | 2023-02-14 | |
| 2022-06-30 | $146,395 | 10,390 | Shares | Other | 2022-08-15 | |
| 2021-12-31 | $1,999,934 | 85,687 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,142,324 | 128,978 | Shares | Sole | 2021-12-01 | |
| 2020-09-30 | $6,187,500 | 150,000 | Call | Sole | 2020-11-16 | |
| 2020-09-30 | $2,799,390 | 67,864 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $377,678 | 7,792 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||